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ABBREVIATIONS  AUC      Area under the receiver operating characteristic curve BMP      Bitmap image file format c      Cost parameter value CEP17     Chromosome 17 centromere CI      Confidence interval CK5      Cytokeratin 5 DAB      Diaminobenzidine DAPI      4',6‐diamidino‐2‐phenylindole DDFS      Distant disease‐free survival DFS      Disease‐free survival DNA      Deoxyribonucleic acid DoG      Difference of Gaussians EGFR      Epidermal growth factor receptor ER      Estrogen receptor FFPE      Formalin‐fixed, paraffin‐embedded FISH      Fluorescence in situ hybridization GB      Gigabyte GHz      Gigahertz H      Haematoxylin H&E      Haematoxylin & Eosin HCl      Hydrochloric acid HER1      Human epidermal growth factor receptor HER2      Human epidermal growth factor receptor 2 HRP      Horseradish peroxidase IHC      Immunohistochemistry JPEG      Joint Photographic Experts Group (compression format) JPEG2000    JPEG 2000 compression format Ki‐67      Ki‐67 protein LBP      Local binary patterns LBP/C     LBP and contrast hybrid feature p53      Tumor protein 53 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Publication  I (HER2 FISH)  II (Ki­67 IHC)  III (Texture) 
Kappa value*  0.82  0.57  0.93 









Characteristic  Value  P Age at diagnosis (y)  < 35  0.0008 Method of detection  Mammography screening  0.0001 Primary tumor diameter (cm)  < 1 > 2  < 0.0001 No. of positive axillary nodes  >= 1  0.0142 Histological grade  1 2‐3  < 0.0001 Histological type  Lobular Ductal  < 0.0001 ER expression  Positive Negative  < 0.0001 PR expression  Positive Negative  < 0.0001 HER2 amplification  Positive  < 0.0001 HER2 expression  Positive  < 0.0001 p53 expression  Low Moderate‐High  < 0.0001 Molecular subtype  Luminal A Basal HER2+/ER‐/PR‐ Luminal B Five‐marker negative Unclassified 
< 0.0001 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Figure 1: The single snapshot images (on the left) are stitched together to form a virtual slide (on the right)  
 Figure 2: Annotation tool with annotated areas shown as green rectangles on the overview image (top right) 
  41 
 Figure 3: The LBP algorithm (original image (a), 8 pixel neighborhood with pixel values (b), binarised neighborhood (c) and final binary code (d))  
 Figure 4: A graphical user interface of the automated FISH algorithm developed in publication I with a HER2 amplified breast cancer sample 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Figure 5: A graphical user interface of the automated IHC algorithm developed in publication II, original Ki‐67 breast cancer TMA spot  
 Figure 6: A sample result image of the spot shown in figure 5 
  43 
 Figure 7: Sample images of different Ki‐67 expression levels (high extent on the top, moderate extent on the middle and low extent on the bottom) 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Figure 8: A sample of original and result images from publication III, showing automated segmentation of epithelial (red) and stromal (blue) tissue compartments of colorectal cancer TMA spots 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Figure 9: Sample images of the effect of image compression used in publication IV on visual image quality, Ki‐67 breast cancer sample  
 Figure 10: Sample images of the effect of image scaling used in publication IV on visual image quality, Ki‐67 breast cancer sample 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DISCUSSION 
 The automation of high‐throughput quantitative analysis of digitized microscopy images of cancer tissue proved to be feasible and the results are comparable to the results from the conventional visual analyses. The biomarker research community already uses the released algorithms.  In publication I, the kappa value was 0.82, corresponding to almost perfect agreement between visual and automated assessment of HER2 gene copy number by FISH. Comparable statistics from other publications related to this issue are scarce. A correlation coefficient (r=0.92) was reported in a study with 41 breast cancer patients, but agreement figures were not given (Tubbs et al., 2006). The reported correlation coefficient is lower than the correlation coefficient 0.98 in publication I. In 1–2% of breast cancer cases, spatially heterogeneous HER2 amplification has been reported (Bartlett et al., 2001). In these cases, FISH signals need to be evaluated in a larger number of microscopic fields (Hicks and Tubbs, 2005). Compared to conventional epifluorescence microscopy, proper selection of ROIs may be easier using whole‐slide imaging and virtual microscopy, since an overview of the whole specimen is available. Moreover, re‐scoring of specimens is possible without the fading of fluorescence using this approach. The developed automated assessment method could be applied to other FISH studies than HER2 gene copy number enumeration in a straightforward manner. Modifications could be made to cover also other in situ hybridization methods such as silver and chromogenic in situ hybridization.  Considering publication II, there is no consensus for Ki‐67 cut‐off values in the literature, some studies use arbitrary values, some the median, and some divide data according to tertiles (de Azambuja et al., 2007; Stuart‐Harris et al., 2008). In a publication on 265 breast cancer patients, univariate survival analysis was carried out with different Ki‐67 thresholds to aid in selection of the cut‐off value (Jalava et al., 2006). With a selected cut‐off point of 15%, subsequent multivariate analysis resulted in a hazard ratio of 2.02 for visually assessed Ki‐67 proliferation index. This figure is in 95% confidence interval of the results from 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automated Ki‐67 assessment in our study, although the multivariate model was slightly different and the patient series was divided into two groups instead of tertiles. Also the association of the automated assessment of Ki‐67 extent of staining and clinicopathological factors was in line with previous reports for visual assessment (Ahlin et al., 2007; Sihto et al., 2008).  The automated and visual methods for Ki‐67 IHC assessment in publication II showed only moderate agreement with a kappa value of 0.57, but both were significant predictors of distant disease‐free survival in univariate analyses with hazard ratios similar to the previous meta‐analyses, where hazard ratios of 1.93‐2.18 for disease‐free survival (DFS) have been observed (de Azambuja et al., 2007; Stuart‐Harris et al., 2008). However, in multivariate survival analyses, only the automated method remained as a significant predictor of patient outcome. These observations appear to contradict the custom of using the visual method as gold standard.  Visual interpretation has shown to result in variability due to human errors (Camp et al., 2002; Cregger et al., 2006). To reduce the variation, a consensus of two or more experts with a critical review of discrepancies would be needed as gold standard in most of the studies. In high throughput research setting with thousands of samples, lack of resources often limits the possibility to use consensus of multiple experts. Instead of trying to mimic experts’ results, methods could be rated at how they can predict some clinically valid endpoint, such as patient outcome.  The prognostic value of an automated image analysis algorithm is especially relevant in routine breast cancer diagnostic pathology, where results are subsequently used in clinical decisions on the treatment of patients. TMAs with samples from dozens of different patients on a single glass slide were used to study Ki‐67 expression in publication II, whereas whole slide sections are predominantly used in routine diagnostic pathology. The algorithm used in publication II can be extended to selected ROIs from whole slide sections, or even applied to the whole section itself. The usage of multicore TMA slides in routine assessment of prognostic factors in breast cancer has also been suggested with results comparable to whole slide diagnostics (Sapino et al., 2006). 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There are a few drawbacks in the automated Ki‐67 assessment algorithm described in publication II. The first weakness is the manual adjustment of threshold levels needed prior to the batch analysis, where multiple TMA spots are analyzed automatically in series. However, when all the studied specimens were processed and stained with same protocols, a constant threshold was used successfully. Optionally, a method for automated threshold selection could be developed to cover also the possible variations in the sample staining protocols. The achieved results should always be visually reviewed after the analysis as a quality control for the selected threshold.  The automatically assessed intensity of Ki‐67 staining was of only limited prognostic value. The previously reported non‐linear relationship between the amount of antigen and the DAB staining intensity could explain this observation (Fritz et al., 1995). Another weakness of the current computer vision approach is that the unsegmented image of the tissue specimen is analyzed and possible stromal components are included in the automated assessment. The tumor grade and histological type can affect the ratio of stroma to epithelium in the TMA cores. This could have affected the results in publication II. Therefore a subgroup analysis according to histological grade and type was performed, as well as adjustment for these possible confounding factors in a multivariate survival model. The automated assessment of Ki‐67 extent of staining was a significant prognostic factor in all subgroups, except in the poorly differentiated (i.e. grade 3) tumors. This lack of prognostic value of Ki‐67 in grade 3 tumors has been previously reported (Klintman et al., 2010). The stromal part of the tumors could be excluded by using a preprocessing step with a tissue classifier, such as the one described in publication III. Commercial image analysis software systems have already incorporated similar preprocessors for stromal exclusion (Turbin et al., 2008; Turashvili et al., 2009). Also the stromal expression of proteins has shown to be of clinical value (Finak et al., 2008; Farmer et al., 2009; Pietras and Ostman, 2010). Thus, in addition to exclusion of stroma, a tissue classifier can be used to analyze the stroma compartment separately. A tissue classifier could also aid in selection of cells and tissue areas for laser capture microdissection (Emmert‐Buck et al., 1996). 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In publication III, the algorithm for texture classification of colorectal cancer specimens based on LBP/C features showed significantly higher classification accuracy as compared to the algorithms based on either Haralick or Gabor features. In addition to the rotation and grayscale invariance of the LBP/C features, which may explain partially this phenomenon, Gabor features may have suffered from previously reported tendency to favor low‐frequency components over high‐frequency components abundant in natural images (Field, 1987). This low‐pass filtering smoothens the details in the images, and small but possibly important structures for the correct classification of the cancer tissue may be lost. The direct comparison of the algorithm from publication III with results from previous studies is challenging, mostly due to different tissue materials used in the studies. To enable other researchers to compare their algorithms with the one we constructed, all the images used in publication III were published as a database available online. Also the selection of the features and the classifier, and the selected parameters, makes a direct comparison difficult. The closest comparable study using LBP was based on 43 whole‐slide neuroblastoma samples (Sertel et al., 2009). A binary classification was used to segment the samples into either stroma‐rich or stroma‐poor classes. The reported overall classification accuracy was 88%, compared to over 99% according to our results. The classification in our study was based on square image blocks of approximately 40 micrometers, and the algorithm may have overlooked a few cancerous cells scattered between stromal structures. The algorithm was trained with colorectal cancer samples stained for analysis of EGFR expression. Other types of tumors and stainings can be used for algorithm training, and it would be of interest to see whether algorithms for segmentation of tumor tissue into stromal and epithelial compartments can have more general use in histology as previously suggested (Kayser et al., 2006). The prognostic value of this algorithm remains to be further studied; promising results from similar algorithms have already been reported (Beck et al., 2011). Texture based algorithms have also been applied in quality comparison between different microscopic imaging solutions (Walkowski and Szymas, 2011). 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The publication IV studying the effect of image size reduction on the results of the automated image analysis algorithms suggest that significant amount of data storage space can be saved by using image compression and scaling without compromising the automated assessment results. With the studied algorithms, images can be reduced to less than four percent of the original image sizes. These results are in line with a study where maximum JPEG2000 compression levels (1:46) resulted in good analysis results in low complexity images, but images with higher complexity tolerated only medium JPEG2000 compression levels (1:23) (Lejeune et al., 2011).   As described in the literature (Mulrane et al., 2008; Kayser et al., 2009), the workflow of the pathology laboratories will move towards an increasingly digital environment similar to the digitization that already has occurred in radiology. The pieces of software developed within this thesis are tools that in combination with virtual microscopy have the potential to provide faster, more objective and less laborious sample analysis in histological pathology. Also, inter‐ and intra‐observer reproducibility of the results will be enhanced. Automated quantification of FISH signals can be of clinical value in determining which breast cancer patients would be eligible for HER2 targeted monoclonal antibody therapy. By applying this therapy only to patients with HER2 gene amplification, the treatment can be targeted to patients that are expected to benefit and adverse effects in HER2 negative patients can be avoided. Rational selection of patients for therapy will also have considerable economical effects.  A group of users that could take advantage of high throughput automated image analysis is researchers studying tissue biomarkers. The number of samples is usually high and there is a need for automated solutions for fast translational analysis of clinical correlates. As an example, a slightly modified version of the algorithm created in publication II was already used in automated analysis of more than two thousand patient samples (Sahu et al., 2011). The readout of an IHC staining was available for statistical analysis within 24 hours. Similarly, the automated scoring of HER2 amplification of 36456 FISH spots was performed in 15 minutes, whereas the corresponding visual assessment required an equal 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amount of mouse clicks for the publication I with only 42 patients involved. This visual scoring was performed by the author in multiple sessions over a period of two weeks.  Table 1 summarizes key figures from publications I‐III. Although not directly comparable due to different algorithms, image sizes and hardware used, the analysis time per image has drastically reduced from 10 seconds in publication I to 0.1 seconds in publication III. The processing power of personal computers continues to improve, but also other options such as grid and cloud computing are emerging. In the future, this trend will probably enable even more complicated algorithms to be run real‐time on gigapixel size virtual microscopy images. 
  52 
CONCLUSIONS 
 In this thesis, tools for high‐throughput biomarker research in a digital microscopy environment were created and evaluated. In publication I, the algorithm for automated quantitative assessment of FISH signals to determine the HER2 gene amplification status in breast cancer tissue images proved to be comparable to visual scoring. In publication II, the extent of Ki‐67 staining determined in breast cancer tissue images by the automated algorithm was a significant predictor of patient outcome in both uni‐ and multivariate analyses. In publication III, the automated segmentation tool divided the colorectal cancer images into epithelial and stromal histological classes with high accuracy. In publication IV, image compression and scaling led to significant reductions in image sizes without compromising the results of the algorithms introduced in publications II and III.  The already released algorithms developed in this thesis are freely accessible to be used by the research community, facilitating also the external validation of the algorithms. After further validation studies, the algorithms can potentially be applied in clinical pathology – especially within risk prediction, diagnostics and targeted treatment of cancer patients in a personalized medicine setting. 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